MYGN logo

Myriad Genetics (MYGN) Working Capital

Annual Working Capital

$157.70 M
+$20.30 M+14.77%

01 December 2023

MYGN Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$138.90 M
-$3.80 M-2.66%

01 September 2024

MYGN Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MYGN Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.8%+147.6%
3 y3 years-35.2%-53.0%
5 y5 years-31.7%-35.1%

MYGN Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-43.8%+14.8%-53.0%+147.6%
5 y5 years-43.8%+14.8%-53.0%+147.6%
alltimeall time-64.7%+1777.4%-69.9%+1727.6%

Myriad Genetics Working Capital History

DateAnnualQuarterly
Sept 2024
-
$138.90 M(-2.7%)
June 2024
-
$142.70 M(-1.0%)
Mar 2024
-
$144.20 M(-8.6%)
Dec 2023
$157.70 M(+14.8%)
$157.70 M(+181.1%)
Sept 2023
-
$56.10 M(-23.4%)
June 2023
-
$73.20 M(-38.1%)
Mar 2023
-
$118.30 M(-13.9%)
Dec 2022
$137.40 M(-51.0%)
$137.40 M(-38.4%)
Sept 2022
-
$223.20 M(-9.8%)
June 2022
-
$247.40 M(-5.4%)
Mar 2022
-
$261.40 M(-6.8%)
Dec 2021
$280.50 M(+15.2%)
$280.50 M(-5.1%)
Sept 2021
-
$295.70 M(+10.4%)
June 2021
-
$267.90 M(+48.7%)
Mar 2021
-
$180.20 M(-30.9%)
Dec 2020
$243.50 M(+31.8%)
-
Sept 2020
-
$260.80 M(+41.2%)
June 2020
$184.70 M(-20.0%)
$184.70 M(-23.7%)
Mar 2020
-
$242.00 M(-4.3%)
Dec 2019
-
$252.90 M(+18.1%)
Sept 2019
-
$214.10 M(-7.2%)
June 2019
$230.80 M(+2.4%)
$230.80 M(-1.4%)
Mar 2019
-
$234.00 M(+4.7%)
Dec 2018
-
$223.50 M(-4.4%)
Sept 2018
-
$233.90 M(+3.8%)
June 2018
$225.40 M(+167.7%)
$225.40 M(-5.0%)
Mar 2018
-
$237.20 M(+41.4%)
Dec 2017
-
$167.70 M(-10.0%)
Sept 2017
-
$186.40 M(+121.4%)
June 2017
$84.20 M(-65.2%)
$84.20 M(-33.5%)
Mar 2017
-
$126.60 M(-51.1%)
Dec 2016
-
$258.80 M(+439.2%)
Sept 2016
-
$48.00 M(-80.2%)
June 2016
$242.20 M(+12.7%)
$242.20 M(-20.9%)
Mar 2016
-
$306.30 M(-1.1%)
Dec 2015
-
$309.60 M(+24.7%)
Sept 2015
-
$248.30 M(+15.5%)
June 2015
$214.90 M(-11.1%)
$214.90 M(-0.2%)
Mar 2015
-
$215.25 M(-17.3%)
Dec 2014
-
$260.25 M(-2.8%)
Sept 2014
-
$267.64 M(+10.7%)
June 2014
$241.80 M(-42.4%)
$241.80 M(-9.1%)
Mar 2014
-
$266.01 M(-31.3%)
Dec 2013
-
$387.11 M(+2.0%)
Sept 2013
-
$379.64 M(-9.5%)
June 2013
$419.48 M(+11.1%)
$419.48 M(+6.4%)
Mar 2013
-
$394.08 M(-4.3%)
Dec 2012
-
$411.85 M(+9.0%)
Sept 2012
-
$377.78 M(+0.1%)
June 2012
$377.52 M(-1.7%)
$377.52 M(-1.1%)
Mar 2012
-
$381.62 M(-4.0%)
Dec 2011
-
$397.39 M(+2.6%)
Sept 2011
-
$387.19 M(+0.9%)
June 2011
$383.87 M(-14.0%)
$383.87 M(-2.1%)
Mar 2011
-
$392.23 M(-7.0%)
Dec 2010
-
$421.62 M(-8.5%)
Sept 2010
-
$460.92 M(+3.2%)
June 2010
$446.51 M
$446.51 M(+4.2%)
DateAnnualQuarterly
Mar 2010
-
$428.40 M(+13.3%)
Dec 2009
-
$378.14 M(-2.9%)
Sept 2009
-
$389.36 M(+16.6%)
June 2009
$333.95 M(+10.0%)
$333.95 M(-20.5%)
Mar 2009
-
$420.07 M(+30.0%)
Dec 2008
-
$323.10 M(+3.8%)
Sept 2008
-
$311.37 M(+2.6%)
June 2008
$303.62 M(+39.7%)
$303.62 M(+41.0%)
Mar 2008
-
$215.29 M(+10.6%)
Dec 2007
-
$194.61 M(-3.3%)
Sept 2007
-
$201.28 M(-7.4%)
June 2007
$217.36 M(-3.6%)
$217.36 M(-30.3%)
Mar 2007
-
$311.77 M(+50.0%)
Dec 2006
-
$207.90 M(-3.2%)
Sept 2006
-
$214.86 M(-4.7%)
June 2006
$225.47 M(+100.8%)
$225.47 M(-3.0%)
Mar 2006
-
$232.43 M(-2.4%)
Dec 2005
-
$238.23 M(+126.9%)
Sept 2005
-
$105.01 M(-6.5%)
June 2005
$112.27 M(-8.1%)
$112.27 M(+33.3%)
Mar 2005
-
$84.23 M(-8.3%)
Dec 2004
-
$91.87 M(-9.5%)
Sept 2004
-
$101.52 M(-16.9%)
June 2004
$122.11 M(+46.3%)
$122.11 M(+55.2%)
Mar 2004
-
$78.68 M(+0.6%)
Dec 2003
-
$78.23 M(-8.9%)
Sept 2003
-
$85.91 M(+2.9%)
June 2003
$83.49 M(+46.9%)
$83.49 M(-22.9%)
Mar 2003
-
$108.31 M(-3.3%)
Dec 2002
-
$111.99 M(+99.0%)
Sept 2002
-
$56.29 M(-1.0%)
June 2002
$56.83 M(-45.7%)
$56.83 M(-22.1%)
Mar 2002
-
$73.00 M(-8.2%)
Dec 2001
-
$79.50 M(-5.0%)
Sept 2001
-
$83.66 M(-20.0%)
June 2001
$104.62 M(+82.7%)
$104.62 M(-5.3%)
Mar 2001
-
$110.46 M(+9.2%)
Dec 2000
-
$101.14 M(+52.5%)
Sept 2000
-
$66.34 M(+15.8%)
June 2000
$57.26 M(+581.7%)
$57.26 M(+63.5%)
Mar 2000
-
$35.01 M(+20.7%)
Dec 1999
-
$29.00 M(+67.6%)
Sept 1999
-
$17.30 M(+106.0%)
June 1999
$8.40 M(-61.5%)
$8.40 M(+10.5%)
Mar 1999
-
$7.60 M(-55.3%)
Dec 1998
-
$17.00 M(+73.5%)
Sept 1998
-
$9.80 M(-55.0%)
June 1998
$21.80 M(-43.8%)
$21.80 M(-1.4%)
Mar 1998
-
$22.10 M(-36.5%)
Dec 1997
-
$34.80 M(-16.5%)
Sept 1997
-
$41.70 M(+7.5%)
June 1997
$38.80 M(-6.7%)
$38.80 M(+34.3%)
Mar 1997
-
$28.90 M(-7.1%)
Dec 1996
-
$31.10 M(-26.8%)
Sept 1996
-
$42.50 M(+2.2%)
June 1996
$41.60 M
$41.60 M(-3.5%)
Mar 1996
-
$43.10 M(-31.0%)
Dec 1995
-
$62.50 M

FAQ

  • What is Myriad Genetics annual working capital?
  • What is the all time high annual working capital for Myriad Genetics?
  • What is Myriad Genetics annual working capital year-on-year change?
  • What is Myriad Genetics quarterly working capital?
  • What is the all time high quarterly working capital for Myriad Genetics?
  • What is Myriad Genetics quarterly working capital year-on-year change?

What is Myriad Genetics annual working capital?

The current annual working capital of MYGN is $157.70 M

What is the all time high annual working capital for Myriad Genetics?

Myriad Genetics all-time high annual working capital is $446.51 M

What is Myriad Genetics annual working capital year-on-year change?

Over the past year, MYGN annual working capital has changed by +$20.30 M (+14.77%)

What is Myriad Genetics quarterly working capital?

The current quarterly working capital of MYGN is $138.90 M

What is the all time high quarterly working capital for Myriad Genetics?

Myriad Genetics all-time high quarterly working capital is $460.92 M

What is Myriad Genetics quarterly working capital year-on-year change?

Over the past year, MYGN quarterly working capital has changed by +$82.80 M (+147.59%)